NCT01821261

Brief Summary

Subjects will be given special instructions about eating, smoking and taking care of their teeth during the 18 hours before they come to the dentist's office for screening. At that first visit, they will be examined by a dentist, who will examine their mouths with a dental instrument to determine whether they qualify to participate in the trial. Someone who works for the dentist will also take some oral measurements. Participants who qualify to be in the study will receive a treatment for their gingivitis and have an equal chance of being assigned to one of three treatment groups. Subjects in all three groups will be given toothpaste that is already available in stores. They will brush their teeth twice daily with a one-inch strip of toothpaste in their regular manner. After brushing, subjects in one group will use an experimental mouth rinse that is not available in stores. Another group will be given a mouth rinse to use that is already available in stores, and the third group will not use any mouth rinse at all. After they receive their assigned products subjects will be supervised while they brush their teeth and/or rinse to ensure they understand exactly how to use the products. All other brushing and rinsing over the next three months will be at home, but subjects will be required to keep a diary to record their brushing and rinsing times twice each day. Subjects will be required to bring their diaries and any leftover toothpaste and mouth rinse with them for four more scheduled appointments after about 1 week, 2 weeks, 4 weeks, and 3 months. At those appointments, the dentist will examine their mouths, make sure there are no safety concerns, and examine again to get the measurements needed. One of the dentist's staff members will take other measurements as well. The study will determine the measured effects of the experimental mouth rinse on gingivitis, and compare these results to the mouth rinse that is already available, as well as to using no mouth rinse at all.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Apr 2014

Shorter than P25 for not_applicable

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 22, 2013

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 29, 2013

Completed
1.1 years until next milestone

Study Start

First participant enrolled

April 30, 2014

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2014

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2014

Completed
Last Updated

January 28, 2019

Status Verified

January 1, 2019

Enrollment Period

Same day

First QC Date

March 22, 2013

Last Update Submit

January 25, 2019

Conditions

Keywords

GumsGingivaGingival InflammationGingival Bleeding

Outcome Measures

Primary Outcomes (1)

  • Whole-mouth Mean Bleeding Index (BI) at 3 Months

    Bleeding after periodontal probe will be assessed by scores on a scale of 0-2 using the Gingival Bleeding Index (BI), where 0=Absence of Bleeding after 30 Seconds and 2=Immediate Bleeding.

    3 months

Secondary Outcomes (9)

  • Whole-mouth Mean Bleeding Index (BI)

    within 4 weeks

  • Whole-mouth Mean Modified Gingival Index (MGI)

    within 3 months

  • Whole Mouth Mean Plaque Index (PI)

    within 3 months

  • Mean Area Stain Score for Mesial Region

    within 3 months

  • Mean Area Stain Score for Gingival Region

    within 3 months

  • +4 more secondary outcomes

Study Arms (3)

Mouth Rinse 19668-012

EXPERIMENTAL

Twice each day, brush with about one inch of toothpaste 035000513007 in the usual manner, rinse mouth with water, and then rinse with 20 ml of mouth rinse 19668-012 for 30 seconds and spit it out - do not swallow.

Device: Mouth Rinse 19668-012Drug: Toothpaste 035000513007

Mouth Rinse 500347078842

ACTIVE COMPARATOR

Twice each day, brush with about one inch of toothpaste 035000513007 in the usual manner, rinse mouth with water, and then rinse with 10 ml of mouth rinse 500347078842 for 60 seconds and spit it out - do not swallow. Attention: Toothpastes can stop mouth rinse from working. Rinse your mouth thoroughly with water and wait 5 minutes after brushing your teeth before using the mouth rinse. You can also use the mouthwash at a different time of day.

Drug: Mouth Rinse 500347078842Drug: Toothpaste 035000513007

Toothpaste 035000513007

OTHER

Twice each day, brush with about one inch of toothpaste 035000513007 in the usual manner. Subjects in this arm will not use any mouth rinse.

Drug: Toothpaste 035000513007

Interventions

20 ml of experimental mouth rinse 19668-012 for 30 seconds, twice daily

Mouth Rinse 19668-012

10 ml of mouth rinse 500347078842 for 60 seconds, twice daily

Also known as: Mouth rinse containing Chlorhexidine, Corsodyl Mouthwash
Mouth Rinse 500347078842

Approximately one inch of toothpaste 035000513007, twice daily

Also known as: Toothpaste containing fluoride, Colgate® Cavity Protection Regular
Mouth Rinse 19668-012Mouth Rinse 500347078842Toothpaste 035000513007

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Assessed by site personnel as able to comprehend and follow the requirements of the study in the Portuguese language, and to be available on scheduled visit dates
  • After being informed of all pertinent aspects of the trial, and having all questions answered, voluntarily signed an informed consent document
  • Assessed by the investigator to have gingivitis, and otherwise qualify to be a participant in the trial

You may not qualify if:

  • Relative, partner or staff of any clinical research site personnel
  • Any oral, psychiatric or medical condition (including pregnancy or nursing), laboratory abnormality, or use of experimental or other products that may (per protocol or in the opinion of the investigator) compromise the safety of the participant or the interpretation of study results

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

GingivitisGingival Hemorrhage

Condition Hierarchy (Ancestors)

InfectionsGingival DiseasesPeriodontal DiseasesMouth DiseasesStomatognathic DiseasesOral HemorrhageHemorrhagePathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Michael Lynch, DMD, PhD

    Johnson & Johnson Consumer Inc. (J&JCI)

    STUDY DIRECTOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 22, 2013

First Posted

March 29, 2013

Study Start

April 30, 2014

Primary Completion

April 30, 2014

Study Completion

July 31, 2014

Last Updated

January 28, 2019

Record last verified: 2019-01